Management of chronic HBV‐HDV patients chronic HBV‐HDV infection: A review on new management options-Reference-Cited by-同舟云学术

Management of chronic HBV‐HDV patients chronic HBV‐HDV infection: A review on new management options

Published:2023-12-02 Issue: Volume: Page:
ISSN:2050-6406
Container-title:United European Gastroenterology Journal
language:en
Short-container-title:UEG Journal

Author:

Buti María¹²³^ORCID,Gonzalez Alexia⁴,Riveiro‐Barciela Mar¹²³,Bourliere Marc⁴⁵

Affiliation:

1. Liver Unit Internal Medicine Department Hospital Universitari Valld’Hebron Valld’Hebron Barcelona Hospital Campus Barcelona Spain

2. Department of Medicine Universitat Autònoma de Barcelona Barcelona Spain

3. CIBERehd Instituto Carlos III Barcelona Spain

4. Liver Unit Saint Joseph Hopital Marseille France

5. Aix Marseille University Inserm IRD SESSTIM Sciences Économiques & Sociales de la Santé & Traitement de l’Information Médicale ISSPAM Marseille France

Abstract

AbstractHepatitis D virus was first described by Mario Rizzeto in 1977, and it is considered chronic viral hepatitis with the poorest prognosis. Despite its discovery almost 50 years ago, progress in its diagnosis and treatment has been scarce until recent years. The approval of bulevirtide has shed some light for patients with Chronic Hepatitis D, although important gaps regarding its use in therapy as well as about the epidemiology and diagnosis of the disease need to be addressed.

Publisher

Wiley

Subject

Gastroenterology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ueg2.12494

Reference54 articles.

1. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers.

2. The changing context of hepatitis D

3. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis